Commissioner Von Eschenbach: NCI Director Named Acting Head Of FDA
This article was originally published in The Gray Sheet
Executive Summary
National Cancer Institute Director Andrew von Eschenbach, MD, brings extensive scientific expertise and experience working with Congress as the head of a high-profile federal agency to the role of FDA commissioner
You may also be interested in...
Ex-FDA Commissioner Pleads Guilty To Conflicts, False Statements
Former FDA Commissioner Lester Crawford pleaded guilty in D.C. federal court Oct. 17 to owning company stocks that caused conflicts of interest and to making false statements about those stock holdings during his tenure at the agency
Ex-FDA Commissioner Pleads Guilty To Conflicts, False Statements
Former FDA Commissioner Lester Crawford pleaded guilty in D.C. federal court Oct. 17 to owning company stocks that caused conflicts of interest and to making false statements about those stock holdings during his tenure at the agency
Von Eschenbach Is Likely Nominee For Permanent FDA Commissioner
FDA Acting Commissioner and National Cancer Institute Director Andrew von Eschenbach will likely be nominated by President George W. Bush as the permanent head of the agency, former FDA Associate Commissioner for External Relations Peter Pitts said March 9